Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Amy Lemke, Marc Stapley

Premium

Amy Lemke has been appointed to associate professor in the Institute for Health and Society's Center for Bioethics and Medical Humanities at the Medical College of Wisconsin. In this role, she will advance the center's new Program in Genomics and Ethics to conduct research on ethical issues raised by emerging genomic technologies.

Lemke holds a PhD in public health, community sciences from the University of Illinois-Chicago, and an MS in genetic counseling from the University of California, Berkeley.


Illumina has appointed Marc Stapley to senior vice president and chief financial officer. Christian Henry, who had been serving dual positions as both the company's chief financial officer and general manager of Illumina's genetic analysis business, will continue to head the genetic analysis business. The change will go into effect on Jan. 20.

Stapley joins Illumina from Pfizer, where he served as senior vice president responsible for global financial processes and systems. Previously, he held various senior finance roles at Alcatel-Lucent. He also worked as finance director and controller for several groups at Cadence Design Systems. He holds a BS in mathematics from the University of Reading in the UK and is a member of the Institute of Chartered Accountants in England and Wales.

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.